Human Hepatic Stellate Cells Show Features of Antigen-Presenting Cells and Stimulate Lymphocyte Proliferation
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Following cell activation, hepatic stellate cells (HSCs) acquire proinflammatory and profibrogenic properties. We investigated whether activated HSCs also display immune properties. Here we show that cultured human HSCs express membrane proteins involved in antigen presentation, including members of the HLA family (HLA–I and HLA–II), lipid–presenting molecules (CD1b and CD1c), and factors involved in T–cell activation (CD40 and CD80). Exposure of HSCs to proinflammatory cytokines markedly up–regulates these molecules. Importantly, cells freshly isolated from human cirrhotic livers (in vivo activated HSCs) highly express HLA–II and CD40, suggesting that HSCs can act as antigen–presenting cells (APCs) in human fibrogenesis. We also explored whether human HSCs can efficiently process exogenous antigens. Activated HSCs internalize low– and high–molecular–weight dextran and transferrin, indicating that they can perform fluid–phase and receptor–mediated endocytosis. Moreover, HSCs can perform phagocytosis of macromolecules because they internalize latex particles as well as bacteria. Interestingly, both culture–activated and in vivo activated HSCs express high levels of CD68, a protein involved in antigen trafficking. Finally, we studied whether HSCs modulate T–lymphocyte proliferation. In basal conditions, coculture of irradiated HSCs barely induces allogeneic T–lymphocyte proliferation. However, cytokine–stimulated HSCs stimulate the allogeneic T–lymphocyte response in an HLA–II—dependent manner. In conclusion, human activated HSCs express molecules for antigen presentation, internalize macromolecules, and modulate T–lymphocyte proliferation. These results suggest that HSCs may play a role in the immune function of the liver. (Hepatology 2003;38:919-929).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD74 is expressed by HSCs, can be induced by inflammatory signals such as IFN-γ and can promote immune activation through MHC class II-mediated interactions46,47.”
From Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution (2025) · cites this paper as [47]
In the citing paper
“HSCs can acquire some features of antigen presenting cells (APCs), including expression of major histocompatibility complexes (MHC) class I and II, and T cell-activating costimulatory molecules such as CD86 (40–42), although more recent evidence suggests HSCs have limited APC capabilities in vivo (43).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [40]
Citations
Cites
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Dong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Local control of the immune response in the liver
Knolle, P. A., & Gerken, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017408.x · Cited by 603
Activation of hepatic stellate cells - a key issue in liver fibrosis
Reeves, H. (2002) · Frontiers in Bioscience · doi:10.2741/reeves · Cited by 423
Ramprasad, M. P., Terpstra, V., Kondratenko, N., Quehenberger, O., & Steinberg, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14833 · Cited by 387
Nelson, D. R., Lauwers, G. Y., Lau, J. Y. N., & Davis, G. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70134-x · Cited by 349
Baroni, G. S., D’Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A. M., & Benedetti, A. (1996) · Hepatology · doi:10.1002/hep.510230538 · Cited by 295
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension
Reynaert, H., Thompson, M. G., Thomas, T., & Geerts, A. (2002) · Gut · doi:10.1136/gut.50.4.571 · Cited by 289
Accessory Molecule and Costimulation Requirements for CD4 T Cell Response
Croft, M., & Dubey, C. (1997) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v17.i1.40 · Cited by 225
Marra, F., Valente, A. J., Pinzani, M., & Abboud, H. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116753 · Cited by 197
Research works printed but not linked: 6
- Pinzani, 1999, Immunopathology, 21, 475
- Bataller, 2001, Hepatology, 34, 400a
- Limmer, 2001, Arch Immunol Ther Exp, 49, s7
- Knolle, 1995, Z Gastroenterol, 33, 613
- Looney, 1995, J Rheumatol, 22, 1820
- Antonaci, 2001, Microbios, 106, 203
Cited by
Items 101–200 of 220
Systematic review: hepatic fibrosis – regression with therapy
Zois, C. D., Baltayiannis, G., Karayiannis, P., & Tsianos, E. V. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03840.x · Cited by 36
The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: A concise review
Kim, J., & Kim, Y. J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122547 · Cited by 43
Tissue biopsy monitoring of operational tolerance in liver allograft recipients
Demetris, A. J., & Isse, K. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283615d48 · Cited by 35
Angiotensin II: a key mediator in the development of liver fibrosis and cancer
Saber, S. (2018) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-018-0020-7 · Cited by 35
Models and Mechanisms of Fibrosis Resolution
Snowdon, V., & Fallowfield, J. A. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01400.x · Cited by 40
Danielyan, L., Tolstonog, G. V., Traub, P., Salvetter, J., Gleiter, C. H., Reisig, D., Gebhardt, R., & Buniatian, G. H. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700575 · Cited by 35
Bomble, M., Tacke, F., Rink, L., Kovalenko, E., & Weiskirchen, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.094 · Cited by 38
Rangwala, F. A., Williams, K. P., Smith, G. R., Thomas, Z., Allensworth, J. L., Lyerly, H. K., Diehl, A. M., Morse, M. A., & Devi, G. R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-402 · Cited by 33
“MF-HSCs infiltrate the stroma of HCCs, localizing around tumor sinusoids, fibrous septa and capsules where they elaborate a variety of cytokines, chemokines and growth factors [28,29].”
BackgroundExpression of Fc Fragment Receptors of Immunoglobulin G (Fc?Rs) in Rat Hepatic Stellate Cells
Shen, H., Zhang, M., Kaita, K., Minuk, G. Y., Rempel, J. D., & Gong, Y. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1298-5 · Cited by 35
“Moreover, several CD molecules, such as CD40, CD68, and CD80, are present on the membrane of HSCs (7).”
BackgroundNanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver
Ezhilarasan, D., & Harini, K. S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104731 · Cited by 42
Dong, X., Wu, Z., Li, ., Wang, G., & Zhao, H. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14498 · Cited by 32
Hendrikx, T., Watzenböck, M. L., Walenbergh, S. M. A., Amir, S., Gruber, S., Kozma, M. O., Grabsch, H. I., Koek, G. H., Pierik, M. J., Staufer, K., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0652-0 · Cited by 33
“It was shown that MDA is specifically recognized by hepatic stellate cells via an interaction with CD36 scavenger receptors [28], thereby potentially stimulating the production of collagen and fibronectin, and promoting an immune response towards MDA as human hepatic stellate cells can promote lymphocyte proliferation…”
BackgroundIto Cells, Stellate Cells, and Myofibroblasts: New Actors in Antigen Presentation
Unanue, E. R. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.001 · Cited by 31
“A previous study also documented some antigen-presenting features of human liver stellate cells (Viñas et al., 2003), although it did not investigate antigen presentation except in the limited context of an allogeneic reaction.”
BackgroundAhn, S. Y., Maeng, Y., Kim, Y. R., Choe, Y. H., Hwang, H. S., & Hyun, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1559-4 · Cited by 32
“Activated HSCs also have been reported to highly express HLA family molecules (predominantly HLA class II) and CD40 for antigen presentation [63].”
BackgroundInfluentialAl‐Dhamin, Z., Liu, L., Li, D., Zhang, S., Dong, S., & Nan, Y. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i47.7444 · Cited by 35
Hepatic Stellate Cell Activation and Hepatic Fibrosis Induced by Ischemia/Reperfusion Injury
Cheng, F., Li, Y., Feng, L., & Li, S. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.06.052 · Cited by 33
Anatomy, pathophysiology and basic mechanisms of disease
Crawford, J. M., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00001-5 · Cited by 33
Xia, Y., Chen, R., Ye, S., Sun, R., Chen, J., & Zhao, Y. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9399-3 · Cited by 29
“Previous studies identified HSCs as professional intrahepatic antigen-presenting cells (APCs) that activate T cells, and eliciting a multitude of T cell responses specific for protein and lipid antigens [33, 34].”
BackgroundOberemm, A., Meckert, C., Brandenburger, L., Herzig, A., Lindner, Y., Kalenberg, K., Krause, E., Ittrich, C., Kopp‐Schneider, A., Stahlmann, R., et al. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.061 · Cited by 33
Immunotherapy for liver tumors: present status and future prospects
Matar, P., Alaniz, L. D., Rozados, V. R., Aquino, J. B., Malvicini, M., Atorrasagasti, C., Gidekel, M., Silva, M., Scharovsky, O. G., & Mazzolini, G. D. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-30 · Cited by 32
Structure, Function, and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00001-7 · Cited by 29
Geng, Y., Wang, J., Salas, S. S., Villanueva, A. H., Buist‐Homan, M., Arrese, M. A., Olinga, P., Blokzijl, H., & Moshage, H. J. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31086 · Cited by 28
“On the other hand, it has been shown that HSCs also have immunoregulatory properties, such as presenting antigens and showing phagocytic ability (Jiang et al., 2008; Viñas et al., 2003; Wang et al., 2023; Zhan et al., 2006).”
BackgroundKhadem, F., Gao, X., Mou, Z., Jia, P., Movassagh, H., Onyilagha, C., GOUNNI, A. S., Wright, M. C., & Uzonna, J. E. (2015) · Hepatology · doi:10.1002/hep.28130 · Cited by 28
“Several reports show that HSCs have potent phagocytic properties(13,44) and are capable of antigen presentation in vitro.(12) In addition, it has been shown that activation of HSCs by several agonists such as lipopolysaccharide leads to increased expression of MHC class II and costimulatory molecules.”
BackgroundBioconjugation of Oligonucleotides for Treating Liver Fibrosis
Ye, Z., Houssein, H. S. H., & Mahato, R. I. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0097 · Cited by 28
Pathogenesis of liver damage in HCV-HIV patients.
Bruno, R., Sacchi, P., Puoti, M., Maiocchi, L., Patruno, S. F. A., Cima, S., & Filice, G. (2008) · PubMed · Cited by 30
Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis
Tang, M., Jia, H., Chen, S., Yang, B., Patpur, B. K., Song, W., Chang, Y., Li, J., & Yang, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118619 · Cited by 26
Strowitzki, M. J., Kirchberg, J., Tuffs, C., Schiedeck, M., Ritter, A. S., Biller, M., Harnoss, J. M., Lasitschka, F., Schmidt, T., Radhakrishnan, P., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.003 · Cited by 21
Li, J., Cheng, L.-S., Jia, H., Liu, C., Wang, S., Liu, Y., Shen, Y., Wu, S., Meng, F., Zheng, B., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1353 · Cited by 24
“Intriguingly, activated HSCs behave like antigenpresenting cells (APCs) and regulate T-cell responses.(9,10) A wealth of studies and our previous work have attempted to bridge intrahepatic inflammation and fibrosis pathways by exploring the cellular crosstalk between immune cells and HSCs.”
BackgroundCross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis
Li, H., Ding, P., Peng, B., & Ming, Y. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.04.007 · Cited by 23
Reifart, J., Rentsch, M., Mende, K., Coletti, R., Sobočan, M., Thasler, W. E., & Khandoga, A. (2014) · Transplantation · doi:10.1097/tp.0000000000000461 · Cited by 23
“Indeed, activatedHSCs can stimulate T lymphocytes and cause lymphocyte proliferation due to their function as professional APC.15,33,34 Furthermore, activated HSCs produce chemokines, such as monocyte chemotactic peptide, CCL21, RANTES, and CCR5,12 which could play a role for T-cell activation during inflammation or I…”
BackgroundRecruitment of dendritic cells in human liver with metastases
Gulubova, M. V., Manolova, I., Cirovski, G., & Sivrev, D. P. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9191-1 · Cited by 20
“Recently, it was shown that activated hepatic stellate cells act as non-professional APCs in injured liver and can also express HLA-DR molecules [ 29 ].”
Backgroundα-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer
Evdokimova, V. N., & Butterfield, L. H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.3.325 · Cited by 22
“Stellate cells play a role in promoting hepatic inflammation and uptake and presentation of antigens to T lymphocytes and induce T-cell proliferation in an MHC class II-restricted manner [119] .”
BackgroundInfluentialRojkind, M., & Reyes‐Gordillo, K. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch28 · Cited by 21
Li, J., Jia, M., Liu, Y., She, W., Li, L., Wang, J., & Jiang, W. (2014) · Liver International · doi:10.1111/liv.12589 · Cited by 19
“Since activated HSCs are recently discovered to behave as APC and elicit T-cell proliferation (14, 25), which requires direct contacts between T cells and HSCs, cellular communications between CD4 T cells and HSCs have been frequently discussed (26, 27), and these studies have especially highlighted the immunoinhibito…”
Background“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the Liver
Bogomolova, A., Balakrishnan, A., Ott, M., & Sharma, A. D. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.002 · Cited by 22
The Role of Inflammation and Immunity in the Pathogenesis of Liver Fibrosis
Mehal, W. Z., & Friedman, S. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_10 · Cited by 21
“Stellate cells can also function as antigen-presenting cells ( 80 ) that can stimulate lymphocyte proliferation or apoptosis (81).”
BackgroundGlobal analysis of host tissue gene expression in the invasive front of colorectal liver metastases
Bandapalli, O. R., Geheeb, M., Kobelt, D., Kuehnle, K., Elezkurtaj, S., Herrmann, J., Gressner, A. M., Weiskirchen, R., Beule, D., Blüthgen, N., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21307 · Cited by 22
The liver as an immunological organ
Weiler-Normann, C., & Rehermann, B. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03687.x · Cited by 595
Liu, Y., Li, L., Liu, J., She, W., Shi, J., Li, J., Wang, J., & Jiang, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.001 · Cited by 19
Vacani-Martins, N., Meuser-Batista, M., dos Santos, C. D. L. P., Hasslocher‐Moreno, A. M., & Henriques‐Pons, A. (2021) · Pathogens · doi:10.3390/pathogens10091074 · Cited by 21
Wang, X., Zhou, Y., Wu, Z., Xie, C., Xu, W., Zhou, Q., Yang, D., Zhu, D., Wang, M., & Wang, L. (2024) · iScience · doi:10.1016/j.isci.2024.108896 · Cited by 15
“11,12 They not only promote T cell tolerance but also participate in the microenvironment suitable for LM.”
BackgroundWang, L., Tu, L., Zhang, J., Xu, K., & Qian, W. (2017) · BioMed Research International · doi:10.1155/2017/2540540 · Cited by 18
Mechanisms of liver fibrosis: New insights into an old problem
Wells, R. G. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.10.003 · Cited by 15
Role of T cell death in maintaining immune tolerance during persistent viral hepatitis
Larrubia, J. R., Lokhande, M. U., García-Garzón, S., Miquel, J., Subirá, D., & Sanz‐de‐Villalobos, E. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i12.1877 · Cited by 14
Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
Cacicedo, M. L., Medina‐Montano, C., Kaps, L., Kappel, C., Gehring, S., & Bros, M. (2020) · Cells · doi:10.3390/cells9091985 · Cited by 15
“In this regard, Winau and colleagues demonstrated that HSCs not only are capable of activating CD4+ T cells [117,118] but also showed cross-priming capability, resulting in activation of CD8+ T cells [119].”
BackgroundZhang, M., Wang, F., Zhu, J., Zheng, Y., Zhao, Q., GU, Y.-R., Zhang, Q., Chong, Y., & Gao, Z. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.767 · Cited by 13
“Together with previous studies indicating that HSCs act as antigen-presenting cells (34), the findings of the present study suggest that LMFs are central to the pathogenesis of liver disease and may be important therapeutic targets for reversing liver inflammation.”
Zhang, W., Shao, T., Wang, C., Wang, S., & An, L. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2613502 · Cited by 15
Nuovo, G. J., Suster, D. I., Awad, H., Michaille, J., & Tili, E. (2021) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2021.151881 · Cited by 13
“Further, they also function as antigen presenting cells and their activation, marked by SMA, type I collagen, and S100 expression, plays a key role in the inflammation and fibrosis typical of progressive liver disease [26-28].”
BackgroundDas, D., Fayazzadeh, E., Li, X., Koirala, N., Wadera, A., Lang, M., Zernic, M., Panick, C. E. P., Nesbitt, P., & McLennan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29545 · Cited by 12
Gao, Y., Ren, H., Meng, F., Jin, L., Cheung, E. C., Li, H., Zhao, J., Liu, H., Liu, Z., & Zhang, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154419 · Cited by 12
RetractedEmerging Roles of Perivascular Mesenchymal Stem Cells in Synovial Joint Inflammation
Bedoui, Y., Lebeau, G., Guillot, X., Dargai, F., Guiraud, P., Neal, J. W., Ralandison, S., & Gasque, P. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09958-z · Cited by 15
“They have important immunoregulatory activities and for instance as antigen-presenting cells (Viñas et al. 2003).”
BackgroundAbu-Tair, L., Doron, S., Mahamid, M., Amer, J., & Safadi, R. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.012 · Cited by 12
Immune function of nonparenchymal liver cells
Xing, X., Wu, H., Feng, H., & Yuan, Z. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15018524 · Cited by 10
“HSCs can express many kinds of molecules involved in antigen presentation:human leukocyte antigen (HLA I and HLA II), which participate in protein antigen presentation; cluster of differentiation (CDlb and CDlc), which participate in lipid antigen presentation; co-stimulatory molecules (CD40 and CD80), which are requi…”
BackgroundHura crepitans stem bark extract: A potential remedy to sub-acute liver damage
Owojuyigbe, O. S., Larbie, C., Firempong, C. K., Komlaga, G., Emikpe, B. O., & Oyagbemi, A. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114768 · Cited by 10
Stellate Cells in Hepatic Immunological Tolerance
Gandhi, C. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00014-2 · Cited by 11
Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells
Ho, C., Chang, T., Lin, H., & Wang, S. (2024) · The Journal of Pathology · doi:10.1002/path.6303 · Cited by 8
“Rat HSCs were demonstrated to express Fc γ Rs [15], and human HSCs express several clusters of differentiation markers, exhibit features of antigen-presenting cells, and stimulate T-lymphocyte proliferation [21].”
BackgroundGu, X., Ji, X., Shi, L., Yi, C., Zhao, Y.-P., Wang, A., Lu, L., Yu, W., & Gao, C. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2238-9 · Cited by 8
“tion [47].”
Pancreatic Stellate Cells Do Not Exhibit Features of Antigen-Presenting Cells
Shimizu, K., Hashimoto, K., Tahara, J., Imaeda, H., Andoh, A., & Shiratori, K. (2012) · Pancreas · doi:10.1097/mpa.0b013e31822e673b · Cited by 8
“A number of cells in the liver, including hepatic dendritic cells, Kupffer cells, and sinusoidal endothelial cells, express the molecules required for antigen presentation,10,11 and, interestingly, liver-resident APCs include HSCs.12,13 Antigenpresenting cells capture antigens by multiple pathways, including macropino…”
BackgroundInfluentialHistopathology of Liver Transplantation
Demetris, A. J., Minervini, M. I., Nalesnik, M. A., Randhawa, P. S., & Sasatomi, E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-0268-8.00084-1 · Cited by 7
Cotransplanted hepatic stellate cells enhance vascularization of islet allografts
Yin, Z., Wu, W., Fung, J. J., Lü, L., & Qian, S. (2007) · Microsurgery · doi:10.1002/micr.20365 · Cited by 7
An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis
Baek, J. S., Lee, J. H., Kim, J. H., Cho, S. S., Cho, S. S., Yang, J. H., Shin, E. J., Kang, H., Kim, S., Ahn, S., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116520 · Cited by 8
A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation
Amer, J., Salhab, A., Doron, S., Morali, G. A., & Safadi, R. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23202 · Cited by 7
“We previously showed that CD8 lymphocyte-subsets mediate hepatic fibrosis (8).”
BackgroundHepatic Stellate Cells and Hepatocytes as Liver Antigen-Presenting Cells during B. abortus Infection
Benítez, P. C. A., Viglietti, A. I. P., Elizalde, M. M., Giambartolomei, G. H., Quarleri, J. F., & Delpino, M. V. (2020) · Pathogens · doi:10.3390/pathogens9070527 · Cited by 8
Human hepatic stellate cells in primary culture are safe targets forLeishmania donovani
Rostan, O., Robert-Gangneux, F., Lambert, M., Samson, M., & Gangneux, J. (2012) · Parasitology · doi:10.1017/s0031182012001965 · Cited by 6
“They can otherwise phagocytose latex bead particles, they closely interact with lymphocytes in Disse’s spaces, and stimulate T-cell proliferation, suggesting that they share features of antigen presenting cells (Vinas et al. 2003; Muhanna et al. 2007).”
BackgroundGandhi, C. R. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_5 · Cited by 5
Transplant Immunology in Liver Transplant, Rejection, and Tolerance
Yokoyama, M., Imai, D., Wolfe, S., George, L., Sambommatsu, Y., Khan, A. A., Lee, S. D., Saeed, M. I., Sharma, A. K., Kumaran, V., et al. (2024) · Livers · doi:10.3390/livers4030031 · Cited by 9
“1) [111].”
Gama, J. F. G., Cardoso, L. M. D. F., Bisaggio, R. D. C., Lagrota-Cândido, J., Henriques‐Pons, A., & Alves, L. A. (2022) · Cells · doi:10.3390/cells11152327 · Cited by 4
Cdc42 is crucial for the early regulation of hepatic stellate cell activation
Yuasa, H., Matsubara, T., Urushima, H., Daikoku, A., Ikenaga, H., Kadono, C., Kinoshita, M., Kimura, K., Ishizawa, T., Ohta, K., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00987.2024 · Cited by 5
Zhao, J., Cai, P., Liu, H., Lin, R., Zhang, X., Luo, L., Li, L., & Ma, J. (2026) · Development · doi:10.1242/dev.205270 · Cited by 4
Allele HLA‐DQB1*06 reduces fibrosis score in patients with non‐alcoholic fatty liver disease
Tan, H., Zain, S. M., Eng, H. M., Mohamed, Z., Mahadeva, S., Chan, W., Lau, P. C., Basu, R. C., & Mohamed, R. B. (2020) · Hepatology Research · doi:10.1111/hepr.13525 · Cited by 6
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 5
Bansal, M. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00008-0 · Cited by 3
Discoidin Domain Receptors in Liver Fibrosis
Olaso, E., Márquez, J., Benedicto, A., Badiola, I., & Arteta, B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6383-6_16 · Cited by 2
Kao, C., & Ho, C. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01502-z · Cited by 2
Uptake Behavior of Embryonic Chick Liver Cells
Kanai, M., Murata, Y., Herbert, D., & Soji, T. (2007) · The Anatomical Record · doi:10.1002/ar.20557 · Cited by 4
The Liver and the Immune System
Knolle, P. A. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50014-0 · Cited by 2
Cellular and Molecular Pathobiology of Liver Fibrosis and its Pharmacological Intervention
Friedman, S. L. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch6b · Cited by 2
Microanatomy and Immunity in the Liver
Liew, P. X., & Kubes, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.07007-7 · Cited by 3
ABC transporters as therapeutic targets for liver fibrosis
Rehman, A. U. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 3
Bataller, R. A., & Brenner, D. A. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch29 · Cited by 4
Self-citationAcute bacterial and viral infections
Juanola, O., Caparrós, E., & Francés, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00011-5 · Cited by 1
Can Proteomic Profiling Identify Biomarkers and/or Therapeutic Targets for Liver Fibrosis?
Katrinli, Ş., Doğanay, H. L., Özdil, K., & Doğanay, G. D. (2017) · InTech eBooks · doi:10.5772/65608
“Activated HSCs also release inflammatory chemocines, secrete cell adhesion molecules, and mediate activation of lymphocytes [36].”
BackgroundImmunopathology of the Hepatobiliary System
Brown, D. L. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_7 · Cited by 2
Knolle, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00009-7 · Cited by 1
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-540-93842-2_3 · Cited by 3
Siegel, P. M., Nyström, H., & Brodt, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91706-3.00011-4 · Cited by 1
Roch, T., Paniskaki, K., Wehler, P., Thieme, C. J., Moradian, H., Blazquez‐Navarro, A., Anft, M., Reinke, P., Westhoff, T. H., Stervbo, U., et al. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02298-2 · Cited by 1
Innate Immunity and Disorders of the Liver
Heikenwälder, M. F., Knolle, P. A., & Protzer, U. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_6 · Cited by 1
Extracellular matrix remodelling and matrix metalloproteinases in the liver
Clément, B. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8585-9_9 · Cited by 1
“HSC and myofibroblasts perpetuate the inflammation process by activating lymphocytes through chemokines, e.g., MCP-1 and RANTES [ 26 ].”
BackgroundGeneration of Hepatocyte-Like Cells by Different Strategies for Liver Regeneration
Yang, Y., Li, X., Liu, W., Chen, J., Liu, C., Cai, Y., Song, Y., Tang, Q., Zhang, C., & He, Z. (2018) · Nano LIFE · doi:10.1142/s1793984418410040 · Cited by 2
Isolation of Hepatic Stellate Cells and Lymphocytes for Co-culture Systems
Kim, H., Kim, K., Hong, S. H., & Jeong, W. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_7 · Cited by 1
Bansal, M. B., & Friedman, S. L. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch6 · Cited by 3
Bansal, M. B., & Friedman, S. L. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch6 · Cited by 5
Role of Immune Response in Nonalcoholic Fatty Liver Disease
Yang, L., & Diehl, A. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_27 · Cited by 4
“In addition, HSCs are also capable of functioning as antigen-presenting cells to activate immune responses ( 43 ).”
BackgroundAngiotensin Converting Enzyme in the Pathophysiology of Liver Fibrosis
Wei, Y. H. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-4483-6_8
On the Origin of Human CD8+ NK-Like T cells: a Role for IL-15 and Hepatocytes
Correia, M. P. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/qggn-v735
The role of platelets in lymphocyte recruitment during liver inflamation
Robinson, J. A. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Bogdanos, D. P., Leung, P. S. C., & Gershwin, M. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00087-2 · Cited by 3
Morphogen and epigenetic regulation of wound healing
Corbett, L. (2015)
Metadata
- Authors
- Viñas, O., Bataller, R., Sancho-Bru, P., Ginès, P., Berenguer, C., Enrich, C., Nicolás, J. M., Ercilla, G., Gallart, T., Vives, J., Arroyo, V., & Rodés, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Ginès, Pere
- ORCID
- Viñas, Odette
- Venue
- Hepatology
- Published
- 2003-10
- Volume
- 38
- Issue
- 4
- Pages
- 919-929
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2158471484
- Cited by
- 223
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 12 · 2023: 5 · 2022: 3 · 2021: 15 · 2020: 10 · 2019: 4 · 2018: 15 · 2017: 13 · 2016: 12 · 2015: 12 · 2014: 9 · 2013: 11 · 2012: 13
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4353 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- hepatic stellate cells, antigen-presenting cells, liver fibrosis, liver cirrhosis, HLA class I and II, CD1b, CD1c, CD40, CD80, T cell activation, antigen processing, endocytosis, phagocytosis, CD68, inflammatory cytokines, liver immunity
- MeSH terms
- CD68 Molecule, Antigen-Presenting Cells, Histocompatibility Antigens Class II, Endocytosis, Humans, Liver, Lymphocyte Activation, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Antigen Presentation, CD40 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.